RxSight, Inc. (RXST) Tops Q4 EPS by 30c

RxSight, Inc. (NASDAQ: RXST) reported Q4 EPS of ($0.45), $0.30 better than the analyst estimate of ($0.75). Revenue for the quarter came in at $16.1 million versus the consensus estimate of $15.78 million.

For earnings history and earnings-related data on RxSight, Inc. (RXST) click here.

You May Also Be Interested In

• Macy's (M) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY Guidance
• Designer Brands Inc. (DBI) Tops Q2 EPS by 8c, Misses on Revenue; Offers FY27 EPS Guidance
• 1-800-FLOWERS.Com (FLWS) Misses Q4 EPS by 10c, Misses on Revenue; Offers Guidance